CGEM vs KEY · $830.3M cap vs P/E 13, rev $7.51B
Cullinan Oncology LLC (CGEM) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
CGEM currently screens at market cap $830.3M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the CGEM and KEY stock pages for the full models.
Not investment advice.